Methods and compositions for treating cancer using peptide nucleic acid-based agents
US-10113169-B2 · Oct 30, 2018 · US
US10446768B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10446768-B2 |
| Application number | US-201715648524-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 13, 2017 |
| Priority date | May 2, 2013 |
| Publication date | Oct 15, 2019 |
| Grant date | Oct 15, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Ordered (e.g., self-assembled) structures, arranged from peptide nucleic acids and/or analogs thereof, are disclosed. The peptide nucleic acids forming the ordered structures comprise from 1 to 10 PNA backbone units, at least one comprising a guanine nucleobase or an analog thereof. Processes of generating the ordered structures, uses thereof and articles-of manufacturing, devices and systems containing same are also disclosed.
Opening claim text (preview).
What is claimed is: 1. A process of generating a composition-of-matter comprising a plurality of peptide nucleic acids arranged in an ordered nanometric or micrometric structure, each of said peptide nucleic acids independently comprising 1 to 10 backbone units, at least one of said backbone units comprising a guanine nucleobase or an analog thereof, the process comprising contacting said plurality of peptide nucleic acids with an aqueous solution under conditions which favor formation of said ordered nanometric or micrometric structure, said aqueous solution having a pH greater than 8. 2. The process of claim 1 , wherein said contacting is such that a concentration of said peptide nucleic acids in said aqueous solution ranges from 10 mg/ml to 100 mg/ml. 3. The process of claim 2 , wherein said concentration is about 50 mg/ml. 4. The process of claim 1 , wherein each of said peptide nucleic acids independently comprises 2 to 6 of said backbone units. 5. The process of claim 1 , wherein each of said peptide nucleic acids comprises 2 of said backbone units and is being a peptide nucleic acid dimer (PNA dimer). 6. The process of claim 5 , wherein each of said peptide nucleic acid dimers is independently selected from the group consisting of AG, CG, GG, GA, GC, and GT. 7. The process of claim 5 , wherein each of said peptide nucleic acid dimers is AG, and wherein said ordered structure is a ribbon-shaped micrometric structure. 8. The process of claim 5 , wherein each of said peptide nucleic acid dimers is CG, and wherein said ordered structure is a fibrillar micrometric structure. 9. The process of claim 5 , wherein each of said peptide nucleic acid dimers is GG, and wherein said ordered structure is a clustered spherical micrometric structure. 10. The process of claim 5 , wherein each of said peptide nucleic acid dimers is GA, and wherein said ordered structure is a micrometric or nanometric folded sheet structure. 11. The process of claim 5 , wherein each of said peptide nucleic acid dimers is GC, and wherein said ordered structure is a fibrillar micrometric structure. 12. The process of claim 5 , wherein each of said peptide nucleic acid dimers is GT, and wherein said ordered structure is a fractal porous nanometric or micrometric structure. 13. The process of claim 1 , wherein said aqueous solution comprises a buffer having pH greater than 8. 14. The process of claim 1 , wherein said aqueous solution comprises a polyamine. 15. The process of claim 14 , wherein a concentration of said polyamine in said aqueous solution ranges from 0.1% to 10%, by volume. 16. The process of claim 1 , wherein said ordered structure is formed at an elongation rate of at least 1 micron per second. 17. The process of claim 1 , wherein at least 10 9 molecules of said peptide nucleic acids organize into said ordered nanometric or micrometric structure per second.
Peptide-nucleic acids (PNAs) · CPC title
containing organic luminescent materials · CPC title
containing oxygen as the only heteroatom · CPC title
containing nitrogen as the only heteroatom · CPC title
Electricity · mapped topic
Related publications grouped by family.
Answers are generated from the same data shown on this page.